NewsVIEW ALL
-
No more meetings for European Stroke Conference
Michael G Hennerici writes: Today, aware of the increasing number of meetings, and faced with expectations of commercial sponsorship both for free participation, and the added risks of dilution of the programs content through marketing oriented commercial symposia, we have decided to stop our regular meetings. We thank the thousands of participants, speakers, members of […]
-
Stroke prevention in patients with patent foramen ovale (PFO)
A substantial proportion of patients with ischaemic stroke present with embolic stroke of undetermined source (ESUS), which is associated with a considerable rate of recurrence. The NAVIGATE ESUS trial aimed to compare the safety and efficacy of oral anticoagulation (rivaroxaban, a factor Xa antagonist) with antiplatelet therapy (aspirin) for secondary stroke prevention in patients […]
-
Stroke mimic diagnoses presenting to a hyperacute stroke unit
Stroke services have been centralised in several countries in recent years. Diagnosing acute stroke is challenging and a high proportion of patients admitted to stroke units are diagnosed as a non-stroke condition (stroke mimics). “Clinical Medicine” Journal from the Royal College of Physicians, London has published a study aims to describe the stroke mimic patient […]
-
Atrial Fibrillation in Transient Ischaemic Attack Versus Ischaemic Stroke
Compared with ischaemic stroke (IS), the association of atrial fibrillation (AF) with transient ischaemic attack (TIA) is less well established. The authors of this study (Stroke,December 2016) aimed to assess the proportion of AF in patients with TIA, and these patients’ characteristics and secondary preventive treatment in comparison to patients with IS. Hospital-based data on […]
